Chemical Compound Review:
AC1LD8VU pyridine-3-carboxylic acid
Synonyms:
2906-42-5, nicotinic acid, [carboxy-14C]-, 3-Pyridinecarboxylic-14C acid (9CI)
- Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Boden, G., Chen, X., Iqbal, N. Diabetes (1998)
- Pyridine nucleotide synthesis in normal and neoplastic human pituitary cells in culture. Gross, C.J., Harris, R.D., Seljeskog, E.L., Henderson, L.M. Cancer (1983)
- The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. Chen, X., Iqbal, N., Boden, G. J. Clin. Invest. (1999)
- Effects of short-term experimental insulin resistance and family history of diabetes on pancreatic beta-cell function in nondiabetic individuals. Rasouli, N., Hale, T., Kahn, S.E., Spencer, H.J., Elbein, S.C. J. Clin. Endocrinol. Metab. (2005)
- Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. Watt, M.J., Southgate, R.J., Holmes, A.G., Febbraio, M.A. J. Mol. Endocrinol. (2004)
- Treatment of type III hyperlipoproteinemia with four different treatment regimens. Hoogwerf, B.J., Bantle, J.P., Kuba, K., Frantz, I.D., Hunninghake, D.B. Atherosclerosis (1984)
- Changes in phosphatidylcholine fatty acid composition are associated with altered skeletal muscle insulin responsiveness in normal man. Clore, J.N., Harris, P.A., Li, J., Azzam, A., Gill, R., Zuelzer, W., Rizzo, W.B., Blackard, W.G. Metab. Clin. Exp. (2000)
- Antihyperlipidemic properties of beta-pyridylcarbinol. A review of preclinical studies. Cohen, M. Life Sci. (1985)
- Phospholipid and eicosanoid signaling disturbances in schizophrenia. Ross, B.M. Prostaglandins Leukot. Essent. Fatty Acids (2003)
- Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated. Johnson, N.A., Stannard, S.R., Rowlands, D.S., Chapman, P.G., Thompson, C.H., Sachinwalla, T., Thompson, M.W. Diabet. Med. (2006)
- Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Mannucci, P.M., Aberg, M., Nilsson, I.M., Robertson, B. Br. J. Haematol. (1975)
- Physical inactivity amplifies the sensitivity of skeletal muscle to the lipid-induced downregulation of lipoprotein lipase activity. Zderic, T.W., Hamilton, M.T. J. Appl. Physiol. (2006)
- On the absorption, distribution and excretion of sorbinicate in the rat and the monkey. Giachetti, C., Mondino, A., Silvestri, S., Zanolo, G., Bramanti, G., Criscuoli, M., Subissi, A. Arzneimittel-Forschung. (1982)
- Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats. Lee, J.Y., Warner, R.B., Brune, M.E., Adler, A.L., Winn, M., De, B., Zydowsky, T.M., Opgenorth, T.J., Kerkman, D.J., DeBernardis, J.F. Am. J. Hypertens. (1994)
- Adsorption of aromatic organic acids onto high area activated carbon cloth in relation to wastewater purification. Ayranci, E., Duman, O. J. Hazard. Mater. (2006)
- Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans. Holmes, A.G., Watt, M.J., Febbraio, M.A. J. Appl. Physiol. (2004)
- Effects of reduced free fatty acid availability on hormone-sensitive lipase activity in human skeletal muscle during aerobic exercise. O'Neill, M., Watt, M.J., Heigenhauser, G.J., Spriet, L.L. J. Appl. Physiol. (2004)
- Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. Gentile, S., Del Vecchio Blanco, C., Persico, M., Marmo, R., Coltorti, M. Hepatogastroenterology (1986)